Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BiommBSP:BIOM3 -2.91%51 Days Inventory is 218.27 as of Mar. 2026, which is 27% above its 10-year median of 171.55. GuruFocus rates BSP:BIOM3 with a GF Score™ of 51/100 and a GF Value™ of R$16.04 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Biomm ranks worse than 52.19% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Biomm's Average Total Inventories for the
three
months ended in Mar. 2026 was R$140.2 Mil. Biomm's Cost of Goods Sold for the
three
months ended in Mar. 2026 was R$58.6 Mil.
Hence, Biomm's Days Inventory for the
three
months ended in Mar. 2026 was 218.27.
The historical rank and industry rank for Biomm's Days Inventory or its related term are showing as below:
BSP:BIOM3'
s Days Inventory Range Over the Past 10 Years
Min: 142.92 Med: 171.55 Max: 89408.66
Current: 190.27
During the past 13 years, Biomm's highest Days Inventory was 89408.66. The lowest was 142.92. And the median was 171.55.
BSP:BIOM3's Days Inventory is ranked worse than 52.19% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs BSP:BIOM3: 190.27
Biomm's Days Inventory
increased
from Mar. 2025 (169.69) to Mar. 2026 (218.27).
It might indicate that Biomm's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Biomm's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.42.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biomm's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.52.
Biomm (BSP:BIOM3) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Biomm's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biomm's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Biomm Days Inventory Related Terms
Biomm Days Inventory Historical Data
* Premium members only.
The historical data trend for Biomm's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:BIOM3 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Biomm's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biomm Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biomm's Days Inventory distribution charts can be found below:
* The bar in red indicates where Biomm's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomm (BSP:BIOM3) has a Days Inventory of 218.27 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biomm and its competitors. This is 27% above median its historical median of 171.55. Over the past decade, Biomm's Days Inventory has ranged from 142.92 to 89,408.66. According to the industry distribution chart, Biomm ranks #333 out of 638 companies in the Biotechnology industry, placing it in the top 52.2%.
Is Biomm's Days Inventory too high?
Biomm's current Days Inventory of 218.27 is 27% above median its 10-year median of 171.55. Over the past 10 years, this metric has ranged from a low of 142.92 to a high of 89,408.66. The Biotechnology industry median Days Inventory is 183.20. Biomm's value of 218.27 is 19.1% above this industry median. Based on the distribution chart, Biomm ranks #333 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Biomm has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biomm's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Biomm ranks #333 out of 638 companies for Days Inventory. This places Biomm in the lower half of its industry. The industry median Days Inventory is 183.20. Biomm's value of 218.27 is 19.1% above this benchmark. Historically, Biomm's own Days Inventory has ranged from 142.92 to 89,408.66 over the past decade. While the company's 10-year median is 171.55 vs. the industry median of 183.20, Biomm has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biomm's current Days Inventory of 218.27 is 19.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biomm and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biomm's current Days Inventory is 218.27, which is 27% above median its own 10-year median of 171.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomm stock overvalued right now?
Based on GuruFocus' analysis, Biomm (BSP:BIOM3) is currently considered Possible Value Trap. The stock's GF Value™ is R$16.04, compared to a current price of R$6.00 — trading 62.6% below its estimated fair value. The current Days Inventory is 218.27, which is 27% above median its 10-year median of 171.55 and 19.1% above the Biotechnology industry median of 183.20. Biomm's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Biomm (BSP:BIOM3), the current Days Inventory is 218.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biomm (BSP:BIOM3) Overvalued in 2026?
Based on GuruFocus' analysis, Biomm stock appears to be undervalued.
The current stock price of R$6.00 is trading 62.6% below its estimated GF Value™ of R$16.04.
GuruFocus considers Biomm to be Possible Value Trap.
Key valuation signals for BSP:BIOM3:
Days Inventory: 218.27 (27% above median its 10-year median of 171.55)
GF Value™: R$16.04 vs. price of R$6.00 (62.6% below fair value)
Industry Position: 19.1% above the Biotechnology median (#333 of 638)
No single metric tells the full story. See the BSP:BIOM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biomm SA is engaged in biotechnological processes for the production of active pharmaceutical ingredients and other industrial purposes, such as enzymes used in the production of Biofuels.The Company is patented for insulin production.The company develops processes for the production of insulin and other biotech products, as well as processes for other industrial applications, such as enzymes that are used in the production of biofuels.
51GF Score
Get the complete analysis for BSP:BIOM3
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:BIOM3 has been successfully added to your 
